These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

653 related articles for article (PubMed ID: 19523495)

  • 1. In vivo imaging of synaptic function in the central nervous system: II. Mental and affective disorders.
    Nikolaus S; Antke C; Müller HW
    Behav Brain Res; 2009 Dec; 204(1):32-66. PubMed ID: 19523495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo imaging of synaptic function in the central nervous system: I. Movement disorders and dementia.
    Nikolaus S; Antke C; Müller HW
    Behav Brain Res; 2009 Dec; 204(1):1-31. PubMed ID: 19523490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating the dopaminergic synapse in vivo. I. Molecular imaging studies in humans.
    Nikolaus S; Antke C; Kley K; Poeppel TD; Hautzel H; Schmidt D; Müller HW
    Rev Neurosci; 2007; 18(6):439-72. PubMed ID: 18330212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortical GABA, striatal dopamine and midbrain serotonin as the key players in compulsive and anxiety disorders--results from in vivo imaging studies.
    Nikolaus S; Antke C; Beu M; Müller HW
    Rev Neurosci; 2010; 21(2):119-39. PubMed ID: 20614802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating the dopaminergic synapse in vivo. II. Molecular imaging studies in small laboratory animals.
    Nikolaus S; Larisch R; Beu M; Antke C; Kley K; Forutan F; Wirrwar A; Müller HW
    Rev Neurosci; 2007; 18(6):473-504. PubMed ID: 18330213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine and the diseased brain.
    Kienast T; Heinz A
    CNS Neurol Disord Drug Targets; 2006 Feb; 5(1):109-31. PubMed ID: 16613557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson's disease, schizophrenia and attention deficit hyperactivity disorder.
    Mehler-Wex C; Riederer P; Gerlach M
    Neurotox Res; 2006 Dec; 10(3-4):167-79. PubMed ID: 17197367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Alterations in the pattern of dopaminergic markers in attention-deficit/hyperactivity disorder].
    Díaz-Heijtz R; Mulas F; Forssberg H
    Rev Neurol; 2006 Feb; 42 Suppl 2():S19-23. PubMed ID: 16555214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo PET study of 5HT(2A) serotonin and D(2) dopamine dysfunction in drug-naive obsessive-compulsive disorder.
    Perani D; Garibotto V; Gorini A; Moresco RM; Henin M; Panzacchi A; Matarrese M; Carpinelli A; Bellodi L; Fazio F
    Neuroimage; 2008 Aug; 42(1):306-14. PubMed ID: 18511303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Posttraumatic stress disorder (PTSD) as a consequence of the interaction between an individual genetic susceptibility, a traumatogenic event and a social context].
    Auxéméry Y
    Encephale; 2012 Oct; 38(5):373-80. PubMed ID: 23062450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Region-Specific Regulation of Presynaptic Dopamine Homeostasis by D
    Gowrishankar R; Gresch PJ; Davis GL; Katamish RM; Riele JR; Stewart AM; Vaughan RA; Hahn MK; Blakely RD
    J Neurosci; 2018 Jun; 38(23):5302-5312. PubMed ID: 29739866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cocaine, metamfetamine, and MDMA abuse: the role and clinical importance of neuroadaptation.
    Seger D
    Clin Toxicol (Phila); 2010 Aug; 48(7):695-708. PubMed ID: 20849328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin 2A receptor, serotonin transporter and dopamine transporter alterations in dogs with compulsive behaviour as a promising model for human obsessive-compulsive disorder.
    Vermeire S; Audenaert K; De Meester R; Vandermeulen E; Waelbers T; De Spiegeleer B; Eersels J; Dobbeleir A; Peremans K
    Psychiatry Res; 2012 Jan; 201(1):78-87. PubMed ID: 22285716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine transporter imaging in adult patients with attention-deficit/hyperactivity disorder.
    Hesse S; Ballaschke O; Barthel H; Sabri O
    Psychiatry Res; 2009 Feb; 171(2):120-8. PubMed ID: 19176281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoaminergic hypo- or hyperfunction in adolescent and adult attention-deficit hyperactivity disorder?
    Nikolaus S; Mamlins E; Giesel FL; Schmitt D; Müller HW
    Rev Neurosci; 2022 Jun; 33(4):347-364. PubMed ID: 34378877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoamine neurocircuitry in depression and strategies for new treatments.
    Hamon M; Blier P
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():54-63. PubMed ID: 23602950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The dopamine transporter: characterization and physiopathologic implications].
    Thibaut F; Vaugeois JM; Petit M
    Encephale; 1995; 21(6):445-51. PubMed ID: 8674469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders.
    van der Stelt M; Di Marzo V
    Eur J Pharmacol; 2003 Nov; 480(1-3):133-50. PubMed ID: 14623357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profound changes in dopaminergic neurotransmission in the prefrontal cortex in response to flattening of the diurnal glucocorticoid rhythm: implications for bipolar disorder.
    Minton GO; Young AH; McQuade R; Fairchild G; Ingram CD; Gartside SE
    Neuropsychopharmacology; 2009 Sep; 34(10):2265-74. PubMed ID: 19494803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding.
    Cervenka S; Pålhagen SE; Comley RA; Panagiotidis G; Cselényi Z; Matthews JC; Lai RY; Halldin C; Farde L
    Brain; 2006 Aug; 129(Pt 8):2017-28. PubMed ID: 16816393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.